Invention Grant
- Patent Title: Compounds and methods for treating pain
-
Application No.: US16573192Application Date: 2019-09-17
-
Publication No.: US11053307B2Publication Date: 2021-07-06
- Inventor: Darren Schofield , Matthew Alexander Sleeman , Iain Patrick Chessell , Jonathan Hatcher , David Lowe
- Applicant: MedImmune Limited
- Applicant Address: GB Cambridge
- Assignee: MedImmune Limited
- Current Assignee: MedImmune Limited
- Current Assignee Address: GB Cambridge
- Agency: McCarter & English, LLP
- Agent Marcie B. Clarke
- Main IPC: C07K16/22
- IPC: C07K16/22 ; C07K14/715 ; C07K14/48 ; C07K14/705 ; A61K39/00

Abstract:
This disclosure provides compositions and methods for controlling pain. In particular the disclosure provides a method for controlling pain comprising co-administration of an NGF antagonist and a TNFα antagonist. The NGF antagonist and the TNFα antagonist can be separate molecules or part of a multifunctional polypeptide, e.g., a multispecific binding molecule that comprises an NGF antagonist domain and a TNFα antagonist domain. This disclosure also provides multifunctional polypeptides, e.g., multispecific binding molecules, comprising an NGF antagonist domain, and a TNFα antagonist domain. The method provides improved pain control. Administration of an NGF antagonist and a TNFα antagonist as provided herein can control pain in the subject more effectively than an equivalent amount of the NGF antagonist or the TNFα antagonist administered alone.
Information query